Sabri Mohammad Reza, Tavana Esfandiar Najafi, Ahmadi Alireza, Hashemipour Mahin
Department of Pediatrics, Child Growth and Development Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Department of Pediatrics, Isfahan University of Medical Sciences, Isfahan, Iran.
Int J Prev Med. 2014 Aug;5(8):999-1004.
Considering the importance of improvement of endothelial function in patients with type 1 diabetes mellitus (DM) and to prevent its related micro- and macro-vascular complications; in this study, the effect of vitamin C administration on improving endothelial function of children with type 1 diabetes was investigated.
In this analytic-experimental study, children with type 1 DM aged 6-18 years and a group of healthy children enrolled. Vitamin C (250 mg/daily) administrated for the two studied groups for 1-month. Endothelial function evaluated by flow-mediated dilatation (FMD) and intima-media thickness (IMT) measurement using vascular Doppler ultrasonography, before and after trial.
In this study, 18 patients with type 1 diabetes (DM) and 19 normal children as the control group were studied. After vitamin C administration IMT reduced in all studied groups (P < 0.05). FMD increased in all studied groups, but it was significant only in the control group (P = 0.02 in the control group and P = 0.07 in patients with DM). Mean differences of IMT 2 - IMT 1, FMD 2 - FMD 1 and left ventricular (LV) mass 2 - LV mass 1 and blood pressure (BP) were not significantly different in two studied groups (P > 0.05). Mean differences of IMT 2 - IMT 1, FMD 2 - FMD 1, LV mass 2 - LV mass 1 and BP were not significantly different in patients with HbA1c ≤ 7 g/dl and those with HbA1c >7 g/dl and control group (P > 0.05).
The findings of the current study indicated that vitamin C may have a protective effect on endothelial dysfunction, but regarding its effectiveness among the high-risk population such as diabetic patients with and without appropriate glycemic control the study was not sufficiently powered due to its small sample size.
鉴于改善1型糖尿病(DM)患者的内皮功能并预防其相关微血管和大血管并发症的重要性;在本研究中,调查了给予维生素C对改善1型糖尿病儿童内皮功能的影响。
在这项分析性实验研究中,纳入了6至18岁的1型糖尿病儿童和一组健康儿童。两个研究组均给予维生素C(每日250毫克),持续1个月。在试验前后,使用血管多普勒超声通过血流介导的血管舒张(FMD)和内膜中层厚度(IMT)测量来评估内皮功能。
在本研究中,研究了18例1型糖尿病患者和19名正常儿童作为对照组。给予维生素C后,所有研究组的IMT均降低(P < 0.05)。所有研究组的FMD均增加,但仅在对照组中具有统计学意义(对照组P = 0.02,糖尿病患者组P = 0.07)。两个研究组的IMT 2 - IMT 1、FMD 2 - FMD 1以及左心室(LV)质量2 - LV质量1和血压(BP)的平均差异无统计学意义(P > 0.05)。HbA1c≤7 g/dl的患者、HbA1c>7 g/dl的患者以及对照组的IMT 2 - IMT 1、FMD 2 - FMD 1、LV质量2 - LV质量1和BP的平均差异无统计学意义(P > 0.05)。
本研究结果表明,维生素C可能对内皮功能障碍具有保护作用,但由于样本量小,对于糖尿病患者等高危人群,无论血糖控制是否适当,其有效性的研究力度不足。